Molecular Determinants of Intravitreal Anti-VEGF Durability: Drug Architecture, Intraocular Pharmacokinetics, Target Biology and Treatment Resistance
Georgios D. Panos, Theo Empeslidis, Efstratia Amaxilati, Georgios N. Tsiropoulos, Nikolaos Topouzis, Panagiotis A.G. Konstas, Eleftherios Chatzimichail, Zisis Gatzioufas, Winfried Amoaku · 2026
Read Molecular Determinants of Intravitreal Anti-VEGF Durability: Drug Architecture, Intraocular Pharmacokinetics, Target Biology and Treatment Resistance by Georgios D. Panos, Theo Empeslidis, Efstratia Amaxilati, Georgios N. Tsiropoulos, Nikolaos Topouzis, Panagiotis A.G. Konstas, Eleftherios Chatzimichail, Zisis Gatzioufas, Winfried Amoaku (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13566860.txt.
Description
Georgios Panos and co-authors review eye drugs in a 2026 paper on how long each shot lasts. The drugs block a growth signal called VEGF and are shot into the eye to treat wet macular disease and swelling from diabetes or blocked veins. They work well, but patients face shot after shot. Doctors often use how long a drug stays in the eye as a short way to judge lasting power.
The review argues that lasting power comes from a whole system, not one number. Dose, drug shape, size, grip on the target, and how the target renews all play a part. Trials of five named drugs show longer gaps can come from a bigger first dose or wider action, with no change in how fast the drug leaves. New depots and gene methods may stretch gaps further.
Catalog record
| CREATOR | Georgios D. Panos, Theo Empeslidis, Efstratia Amaxilati, Georgios N. Tsiropoulos, Nikolaos Topouzis, Panagiotis A.G. Konstas, Eleftherios Chatzimichail, Zisis Gatzioufas, Winfried Amoaku |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 149 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |